Frontiers of Medicine

, Volume 12, Issue 1, pp 84–91 | Cite as

Etiology of invasive candidosis agents in Russia: a multicenter epidemiological survey

  • N. V. Vasilyeva
  • E. R. Raush
  • M. V. Rudneva
  • T. S. Bogomolova
  • A. E. Taraskina
  • Yong Fang
  • Fengmin Zhang
  • N. N. Klimko
Research Article
  • 10 Downloads

Abstract

A multicenter prospective epidemiological survey on the etiologic agents of invasive candidosis was conducted in Russia in the period of 2012–2014. Samples were collected from 284 patients with invasive candidosis and Candida species isolated by culture. The species were identified by DNA sequencing and MALDI-TOF massspectrometry. A total of 322 isolates were recovered, in which 96% of Сandida species belonged to six major species, namely, C. albicans (43.2%), C. parapsilosis (20.2%), C. glabrata (11.5%), C. tropicalis (9.6%), C. krusei (6.2%), and C. guilliermondii (5.3%). Most Candida species were isolated from blood samples (83.23%). Notably, the prevalence rate of C. albicans reduced from 52.38% to 32.79% (2012 vs. 2014) (P = 0.01) whereas that of non-C. albicans increased from 47.62% (2012) to 67.21% (2014) (P < 0.01). Species distribution differed among geographical regions; specifically, the prevalence rate of C. albicans as an etiologic agent of invasive candidosis in Siberian Federal region was significantly higher than that in other Federal regions. Results indicated a shift from C. albicans to non-C. albicans. Therefore, a detailed investigation on the contributing factors and appropriate treatment of invasive candidosis is needed.

Keywords

prevalence Candida species invasive candidosis nosocomial etiology MALDI-TOF mass-spectrometry candidemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgements

We acknowledge the management of Russian Ministry of Health and Sino-Russian Medical Research Center of Heilongjiang Academy of Medical Sciences, China which offered finance support, laboratory space, and equipment used in this research. We also acknowledge specific clinics and hospitals that helped in collecting clinical samples. This research was financially supported by Russian Ministry of Health, Russia; Sino-Russian Medical Research Center of Heilongjiang Academy of Medical Sciences, China (Nos. CR201406 and CR201502), National Natural Science Foundation of China (No.81301703) and Natural Science Foundation of Heilongjiang Province, China (No. QC2013C078).

References

  1. 1.
    Barchiesi F, Orsetti E, Gesuita R, Skrami E, Manso E; Candidemia Study Group. Epidemiology, clinical characteristics, and outcome of candidemia in a tertiary referral center in Italy from 2010 to 2014. Infection 2016; 44(2): 205–213CrossRefPubMedGoogle Scholar
  2. 2.
    Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 2012; 18(Suppl 7): 19–37CrossRefPubMedGoogle Scholar
  3. 3.
    Lionakis MS, Netea MG. Candida and host determinants of susceptibility to invasive candidiasis. PLoS Pathog 2013; 9(1): e1003079CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005; 41(9): 1232–1239CrossRefPubMedGoogle Scholar
  5. 5.
    Tortorano AM, Kibbler C, Peman J, Bernhardt H, Klingspor L, Grillot R. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27(5): 359–366CrossRefPubMedGoogle Scholar
  6. 6.
    Hassan I, Powell G, Sidhu M, Hart WM, Denning DW. Excess mortality, length of stay and cost attributable to candidaemia. J Infect 2009; 59(5): 360–365CrossRefPubMedGoogle Scholar
  7. 7.
    Bongomin F, Gago S, Oladele R, Denning DW. Global and multinational prevalence of fungal diseases—estimate precision. J Fungi 2017; 3(4): 57–86CrossRefGoogle Scholar
  8. 8.
    Klimko N, Kozlova Y, Khostelidi S, Shadrivova O, Borzova Y, Burygina E, Vasilieva N, Denning DW. The burden of serious fungal diseases in Russia. Mycoses 2015; 58(Suppl 5): 58–62CrossRefPubMedGoogle Scholar
  9. 9.
    Pfaller MA, Pappas PG, Wingard JR. Invasive fungal pathogens: current epidemiological trends. Clin Infect Dis 2006; 43(Supplement 1): S3–S14CrossRefGoogle Scholar
  10. 10.
    Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67(5): 1181–1187CrossRefPubMedGoogle Scholar
  11. 11.
    Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20(1): 133–163CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Tan BH, Chakrabarti A, Li RY, Patel AK, Watcharananan SP, Liu Z, Chindamporn A, Tan AL, Sun PL, Wu UI, Chen YC; Asia Fungal Working Group (AFWG). Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. Clin Microbiol Infect 2015; 21(10): 946–953CrossRefPubMedGoogle Scholar
  13. 13.
    Pfaller M, Neofytos D, Diekema D, Azie N, Meier-Kriesche HU, Quan SP, Horn D. Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008. Diagn Microbiol Infect Dis 2012; 74(4): 323–331CrossRefPubMedGoogle Scholar
  14. 14.
    Montagna MT, Caggiano G, Lovero G, De Giglio O, Coretti C, Cuna T, Iatta R, Giglio M, Dalfino L, Bruno F, Puntillo F. Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project). Infection 2013; 41(3): 645–653CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012; 18(Suppl 7): 9–18CrossRefPubMedGoogle Scholar
  16. 16.
    Clinical and Laboratory Standards Institute (CLSI). Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; approved guideline. CLSI document MM18-A. Wayne, Pennsylvania, 2008Google Scholar
  17. 17.
    Biotyper MALDI. 3.1. User manual revision 1. Bruker Daltonics, Bremen: 2012Google Scholar
  18. 18.
    Bassetti M, Peghin M, Carnelutti A, Righi E, Merelli M, Ansaldi F, Trucchi C, Alicino C, Sartor A, Toniutto P, Wauters J, Laleman W, Tascini C, Menichetti F, Luzzati R, Brugnaro P, Mesini A, Raviolo S, De Rosa FG, Lagunes L, Rello J, Dimopoulos G, Colombo AL, Nucci M, Vena A, Bouza E, Muñoz P, Tumbarello M, Losito R, Martin-Loeches I, Viscoli C. Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intraabdominal candidiasis: a multicenter study. Intensive Care Med 2017; 43(4): 509–518CrossRefPubMedGoogle Scholar
  19. 19.
    Trouvé C, Blot S, Hayette MP, Jonckheere S, Patteet S, Rodriguez-Villalobos H, Symoens F, Van Wijngaerden E, Lagrou K. Epidemiology and reporting of candidaemia in Belgium: a multicentre study. Eur J Clin Microbiol Infect Dis 2017; 36(4): 649–655CrossRefPubMedGoogle Scholar
  20. 20.
    Sasso M, Roger C, Sasso M, Poujol H, Barbar S, Lefrant JY, Lachaud L. Changes in the distribution of colonising and infecting Candida spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: a 10-year study. Mycoses 2017 Jul 31 [Epub ahead of print] https://doi.org/10.1111/myc.12661Google Scholar
  21. 21.
    Quindós G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol 2014; 31(1): 42–48CrossRefPubMedGoogle Scholar
  22. 22.
    Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care 2011; 1(1): 37CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Yang CW, Barkham TM, Chan FY, Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 2003; 41(1): 472–474CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Puig-Asensio M, Padilla B, Garnacho-Montero J, Zaragoza O, Aguado JM, Zaragoza R, Montejo M, Muñoz P, Ruiz-Camps I, Cuenca-Estrella M, Almirante B; CANDIPOP Project; GEIHGEMICOMED (SEIMC); REIPI. Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. Clin Microbiol Infect 2014; 20(4): O245–O254CrossRefPubMedGoogle Scholar
  25. 25.
    Fu J, Ding Y, Wei B, Wang L, Xu S, Qin P, Wei L, Jiang L. Epidemiology of Candida albicans and non-C. albicans of neonatal candidemia at a tertiary care hospital in western China. BMC Infect Dis 2017; 17(1): 329CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Pfaller MA, Diekema DJ, Rinaldi MG, Barnes R, Hu B, Veselov AV, Tiraboschi N, Nagy E, Gibbs DL. Results from the AR-TEMIS DISK global antifungal surveillance study: a 6.5-year analysis of the worldwide susceptibility of yeasts to fluconazole and voricon-azole using standardized disk diffusion testing. J Clin Microbiol 2005; 43 (12): 5848–5859CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Pfaller MA, Jones RN, Castanheira M. Regional data analysis of Candida non-albicans strains collected in United States medical sites over a 6-year period, 2006–2011. Mycoses 2014; 57(10): 602–611CrossRefPubMedGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag GmbH Germany 2018

Authors and Affiliations

  • N. V. Vasilyeva
    • 1
    • 2
    • 3
  • E. R. Raush
    • 1
  • M. V. Rudneva
    • 2
  • T. S. Bogomolova
    • 1
    • 2
  • A. E. Taraskina
    • 2
  • Yong Fang
    • 3
  • Fengmin Zhang
    • 3
  • N. N. Klimko
    • 4
  1. 1.Department of Medical MicrobiologyNorth-Western State Medical University named after I.I. MechnikovSt. PetersburgRussia
  2. 2.Kashkin Research Institute of Medical MycologyNorth-Western State Medical University named after I.I. MechnikovSt. PetersburgRussia
  3. 3.Sino-Russia Institute of Infection and Immunity, Department of MicrobiologyHarbin Medical UniversityHarbinChina
  4. 4.Department of Clinical Mycology, Allergy and ImmunologyNorth-Western State Medical University named after I.I. MechnikovSt. PetersburgRussia

Personalised recommendations